Endo Pharmaceuticals Inc. v. Sandoz Inc.
1:14-cv-01388
Overview
Parties
Defendant
Sandoz Inc. Operating Company
Represented By
1 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Plaintiff
Mallinckrodt LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Endo Pharmaceuticals Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,808,737 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,789,103 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,389,443 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2022031368 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2008031899 | US Continuation / Sibling | View Official Patent → |
Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.
Endo Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited
Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals LLC
Endo Pharmaceuticals Inc. v. Par Pharmaceutical Companies Inc.
Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc.
Endo Pharmaceuticals Inc. v. Impax Laboratories Inc.
Endo Pharmaceuticals Inc. v. Actavis LLC
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8808737
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
|
Filed: 2010-03-03
Issued: 2014-08-19
|
Active (3.3 yrs remaining)
Expires: 2030-03-03
|
|
|
US8871779
Process for preparing morphinan-6-one products with low levels of Ξ±,Ξ²-unsaturated ketone compounds
|
Filed: 2007-03-02
Issued: 2014-10-28
|
Active (3.0 yrs remaining)
+996d PTA
Expires: 2029-11-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
8
Dispositive
0
Granted
0
Denied
0
Pending / Review
8
Motions by Category
Key Dispositive Motions & Rulings